Previous Article | Next Article ![]()
Journal of Virology, December 2001, p. 11747-11754, Vol. 75, No. 23
Department of Medicine and Will Rogers
Institute Pulmonary Research Center,1
Departments of Biochemistry and Molecular
Biology2 and Pathology,5
and Institute for Genetic Medicine,3 Keck School
of Medicine, University of Southern California, Los Angeles,
California, and Department of Medicine, Washington University
School of Medicine, St. Louis, Missouri4
Received 30 April 2001/Accepted 21 August 2001
We investigated the use of lentivirus vectors for gene transfer to
quiescent alveolar epithelial cells. Primary rat alveolar epithelial
cells (AEC) grown on plastic or as polarized monolayers on tissue
culture-treated polycarbonate semipermeable supports were
transduced with a replication-defective human immunodeficiency virus-based lentivirus vector pseudotyped with the vesicular stomatitis virus G (VSV-G) protein and encoding an enhanced green fluorescent protein reporter gene. Transduction efficiency, evaluated by confocal microscopy and quantified by fluorescence-activated cell sorting, was
dependent on the dose of vector, ranging from 4% at a multiplicity of
infection (MOI) of 0.1 to 99% at an MOI of 50 for AEC grown on
plastic. At a comparable titer and MOI, transduction of these cells by
a similarly pseudotyped murine leukemia virus vector was ~30-fold
less than by the lentivirus vector. Importantly, comparison of
lentivirus-mediated gene transfer from the apical or basolateral
surface of confluent AEC monolayers (Rt > 2 k Gene transfer to the alveolar epithelium is an
attractive therapeutic approach for a number of acute and chronic
acquired lung diseases, including pulmonary inflammation, pulmonary
edema, acute lung injury and/or acute respiratory distress syndrome, and pulmonary fibrosis (1, 5, 15, 43). In addition, due to
its large surface area and proximity to the vascular endothelium, the
alveolar epithelium represents an attractive target for delivery of
therapeutic genes encoding secreted proteins. However, in contrast to
the large number of studies that have utilized a variety of vectors to
achieve gene transfer to tracheal and bronchial epithelium in the upper
airways, particularly in the context of gene therapy for cystic
fibrosis (54), relatively few studies have examined gene
transfer to the alveolar epithelium of the distal respiratory tract.
Nonviral strategies for delivery of exogenous DNA to the lung have been
limited by low efficiency of transduction (56). Of the
various vectors that have been evaluated for gene therapy thus far,
each exhibits characteristic disadvantages, and none has proven
effective in achieving efficient, long-term expression in the distal
respiratory tract. Due to the relative quiescence of the cells that
constitute the alveolar epithelium, viral vectors must be able to
efficiently transduce cells that are not actively dividing (37,
46). In this regard, adenovirus vectors have been shown to
effectively transduce the alveolar epithelium (15). However, use of these vectors in vivo has been limited by immune responses, which can be especially problematic in lung alveoli due to
the potential for inducing serious pulmonary inflammation (55). In any event, use of this nonintegrating vector
system would require repeated viral administration to achieve long-term gene expression (12). Adeno-associated virus vectors show
episomal expression and eventual integration after cell division and
have been used for gene delivery to the distal respiratory tract
(16, 17). However, their use has been limited by low
packaging capacity and difficulty in obtaining high-titer preparations
(20). Repeated administration of adeno-associated virus
vectors has been limited by development of neutralizing antibodies
(8). Thus, investigation of alternative vectors for gene
delivery to the alveolar epithelium is warranted.
Under normal in vivo conditions, the cells that constitute the alveolar
epithelium undergo very low rates of proliferation (2, 4, 46,
47). The efficiency of standard murine leukemia virus
(MLV)-based retroviruses for gene transfer to the adult alveolar
epithelium is therefore predictably inefficient (14, 50).
This limitation has been partially overcome by inducing cell
proliferation with growth factors (52), but overall
transduction efficiency is still quite low. On the other hand, the
newer lentivirus-based vectors have recently been shown to
transduce several nondividing cell types, including neurons, myocytes,
and tracheal epithelial cells, with long-term persistence of transgene
expression (21, 23, 34, 40). Pseudotyping of the
lentivirus with different fusion proteins has expanded the
range of host cells that can be transduced by these vectors and
allowed the virus to be easily concentrated to high titers,
especially when pseudotyped with the vesicular stomatitis virus G
(VSV-G) protein (38). VSV-G-pseudotyped lentivirus vectors
would therefore appear to be ideally suited for gene transfer to the
relatively quiescent cells of the alveolar epithelium.
To date, studies of lentivirus-based gene transfer in the lung have
focused on transduction of the tracheal or bronchial epithelium of the
proximal airways, but the efficiency of gene transfer has been much
lower than that described in other cell types. In polarized, well-differentiated airway epithelia, only minimal transduction by
VSV-G-pseudotyped vectors introduced from the apical surface (the only
directly accessible surface in vivo) has been observed (21). The use of lentivirus vectors for transduction of
alveolar epithelial cells (AEC) in the distal respiratory tract has not been evaluated to date. In particular, the issue of whether the polarized cells that constitute the alveolar epithelium present a
similar barrier to apical transduction by lentivirus has not been explored.
Over a period of 3 to 4 days, isolated rat type II alveolar (AT2) cells
maintained in primary culture gradually lose the characteristic hallmarks of type II cells, such as lamellar bodies and production of
surfactant-associated proteins, and change morphologically to resemble
alveolar type I (AT1) cells, becoming more flattened with expansive
cytoplasmic processes (6). Concurrently, they begin to
express a number of phenotypic markers specific for alveolar type I
cells in situ, suggesting that AT2 cells in culture are undergoing
transdifferentiation toward a type I cell-like phenotype (9,
10). AT2-to-AT1 cell transdifferentiation occurs in the absence
of appreciable cell division (27). When grown on
semipermeable supports, the cells form polarized high-resistance
monolayers and exhibit active sodium transport that occurs in a
vectorial fashion, similar to that observed in the alveolar epithelium
in vivo (7). Previous studies have demonstrated minimal
DNA synthesis in AEC cultivated in vitro at high density (>2 × 105 cells/cm2) in the
absence of exogenous growth factors, with a nuclear labeling index
consistently on the order of 1 to 3% (26, 27, 28, 46,
48). AEC in primary culture therefore constitute a
well-characterized in vitro model with which to evaluate
characteristics of the polarized and relatively quiescent alveolar epithelium.
In the present report, we have compared the ability of
VSV-G-pseudotyped lentivirus and MLV retrovirus vectors to
transduce AEC in primary culture. Furthermore, the relative
efficiency of transduction of confluent AEC and primary differentiated
tracheal epithelial cells after exposure to lentivirus vectors from
either the apical or basolateral cell surface was examined.
Rat AEC isolation and culture.
AT2 cells were isolated from
the lungs of adult male Sprague-Dawley rats by disaggregation with
elastase (2.0 to 2.5 U/ml) (Worthington Biochemical, Freehold, N.J.),
followed by panning on immunoglobulin G-coated bacteriologic plates
(3, 11). Enriched AT2 cells were resuspended in defined
medium (MDSF) consisting of Dulbecco's modified Eagle medium and
Ham's F-12 nutrient mixture in a 1:1 ratio (DME-F12; Sigma-Aldrich
Chemical, St. Louis, Mo.), supplemented with 1.25 mg of bovine serum
albumin (Collaborative Research, Bedford, Mass.)/ml, 10 mM HEPES, 0.1 mM nonessential amino acids, 2.0 mM glutamine, 100 U of sodium
penicillin G/ml, 100 µg of streptomycin/ml, and 10% newborn bovine
serum (Omega Scientific, Tarzana, Calif.). Cells were seeded onto
plastic, chamber slides or tissue culture-treated polycarbonate
(Nuclepore) filter cups (0.4-µm pore size; 1.1 cm2; Transwell; Corning-Costar, Cambridge, Mass.)
at a density of 1.0 × 106
cells/cm2 and grown to confluence. Media were
changed on the second day after plating and every other day thereafter.
Cultures were maintained in a humidified 5% CO2
incubator at 37°C. AT2 cell purity (>90%) was assessed by staining
freshly isolated cells for lamellar bodies with tannic acid
(29). Cell viability (>90%) was measured by trypan blue
dye exclusion.
RTEC isolation and culture.
Rat tracheal epithelial cells
(RTEC) were isolated from adult male Sprague-Dawley rats by incubation
of tracheas overnight at 4°C in 0.15% pronase (Roche Molecular
Biochemicals, Indianapolis, Ind.). Tracheas were agitated to release
cells that were then disaggregated in DNase I (0.5 mg/ml, 5 min on
ice). Cells were adhered (2 h) to remove fibroblasts; nonadherent cells
were counted, and viability (>90%) was determined by trypan blue dye
exclusion. RTEC were resuspended in defined medium consisting of
DME-F12 supplemented with L-glutamine (6.5 mM),
NaHCO3 (25 mM), insulin (10 µg/ml),
hydrocortisone (0.1 µg/ml), transferrin (5 µg/ml), phosphoethanolamine (50 µM), ethanolamine (80 µM), cholera
toxin (0.1 µg/ml), bovine pituitary extract (0.03 mg/ml), epidermal growth factor (10 ng/ml; Becton Dickinson Labware, Bedford, Mass.), HEPES (30 mM), bovine serum albumin (0.5 mg/ml), retinoic acid (0.05 µM), penicillin (50 U/ml), streptomycin (50 µg/ml), and amphotericin B (0.25 µg/ml) as described by others (22,
35). Cells were seeded (5 × 105
cells/cm2) onto filter cups (0.4-µm pore size;
0.33 cm2; Transwell Clear; Corning-Costar) coated
with rat tail collagen (50 µg/ml; Becton Dickinson Labware) and
maintained in a humidified 5% CO2 incubator at
37°C. Nuserum (10%; Becton Dickinson Labware) was added during the
first 2 days. Cells were maintained with medium in the apical and
basolateral chambers until transmembrane resistance was >300 Measurement of bioelectric properties.
The transepithelial
resistance (Rt) and the spontaneous potential
difference (SPD) of AEC and RTEC grown on filters were measured by
using a rapid screening device (Millicell-ERS; Millipore, Bedford, Mass.) as previously described (24). Short-circuit current
(ISC) was calculated from the relationship
ISC = SPD/Rt. Cell culture media and all other chemicals were purchased from Sigma-Aldrich Chemical unless otherwise noted and were of the highest commercial purity available.
Assessment of alveolar epithelial cell proliferation.
On day
4, AEC grown on plastic in MDSF plus 10% newborn bovine serum
were labeled with bromodeoxyuridine (BrdU; 10 µM), a thymidine analog
that is incorporated into newly synthesized DNA, for 6 h. Cells
were washed twice with phosphate-buffered saline (PBS), released by
incubation for 10 min with 5 µM EDTA, and washed again with PBS.
Cells were fixed, permeabilized, refixed, and treated with DNase by
using the BrdU Flow Kit protocol (BD Pharmingen, San Diego, Calif.).
Samples were stained with a fluorescein isothiocyanate-conjugated anti-BrdU antibody and analyzed by fluorescence-activated cell sorting (FACS).
Vector production and virus preparation
Recombinant lentivirus vector and packaging constructs (generously
provided by L. Naldini, University of Turin, Turin, Italy) were
produced as previously described (34), by using the
constructs shown in Fig. 1. The vector
construct, pRRLhCMVGFPsin, consists of a human immunodeficiency virus
(HIV)-based self-inactivating (SIN) replication-defective lentivirus
transfer vector expressing an enhanced green fluorescent protein (EGFP)
reporter gene driven by the cytomegalovirus (CMV) immediate-early
promoter (57). Human 293T cells (80 to 90% confluence)
were cotransfected by calcium phosphate precipitation with 12 µg of
pRRLhCMVGFPsin, 10 µg of pCMV
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.23.11747-11754.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Vesicular Stomatitis Virus G-Pseudotyped Lentivirus Vectors
Mediate Efficient Apical Transduction of Polarized Quiescent
Primary Alveolar Epithelial Cells
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
· cm2; MOI = 10) revealed efficient transduction
only when VSV-G-pseudotyped lentivirus was applied apically.
Furthermore, treatment with EGTA to increase access to the basolateral
surface did not increase transduction of apically applied virus,
indicating that transduction was primarily via the apical membrane
domain. In contrast, differentiated tracheal epithelial cells were
transduced by apically applied lentivirus only in the presence of EGTA
and at a much lower overall efficiency (~15-fold) than was observed
for AEC. Efficient transduction of AEC from the apical cell surface
supports the feasibility of using VSV-G-pseudotyped lentivirus vectors
for gene transfer to the alveolar epithelium and suggests that
differences exist between upper and lower airways in the polarity of
available receptors for the VSV-G protein.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
· cm2. Medium was then removed from the apical
chamber (typically at days 2 to 4), and cells were maintained at
air-liquid interface (ALI) by daily supplying fresh medium to the
basolateral chamber only. Differentiated, multilayered epithelial cell
populations were assessed by histology of paraffin-embedded sections of
RTEC cultures.
R8.91 for viral packaging, and 8 µg
of pMD.G for VSV-G pseudotyping (58). Virus was isolated
and for some experiments was concentrated through a centrifugal
concentrator (Macrosep; Pall Gelman Laboratory, Ann Arbor, Mich.) with
a 300-kDa molecular mass cutoff and stored at
80°C. Titers of
vector stocks were determined on HeLa cells by FACS with a
Becton-Dickinson FACScan equipped with a 488-nm argon laser and were in
the range of 106 to 108 transducing units
(TU)/ml. MLV-based vectors were generated by using a similar protocol
(44) and similarly pseudotyped with VSV-G.

View larger version (12K):
[in a new window]
FIG. 1.
Vectors used for generation of lentivirus. SIN
lentivirus vectors (pRRLhCMVGFPsin) were used to produce infectious
particles by cotransfection of gag-pol
(pCMV
R8.91) and pMD.G (for VSV-G envelope) into 293T cells.
Viral transduction of AEC. AEC grown on plastic or chamber slides were transduced with lentivirus (multiplicity of infection [MOI] of 0.1 to 50) on day 4 to ascertain a dose-response relationship. Medium was aspirated, and cells were incubated with virus for 1 h in the presence of Polybrene (8 µg/ml). Cells were trypsinized 72 h after transduction, washed, and resuspended in PBS. The efficiency of cell transduction was analyzed by FACS. To confirm that GFP expression was not the result of pseudotransduction, control experiments were performed in the presence of zidovudine (AZT; 200 µM) to inhibit viral reverse transcriptase. The efficiency of transduction of AEC by VSV-G-pseudotyped lentivirus or MLV-based retrovirus of comparable titers were compared and analyzed in a similar fashion. Live gating of viable cells was performed by using forward-scatter and side-scatter parameters, and the percentage of cells exhibiting EGFP fluorescence was quantified on fluorescence channel 1 (FL1).
To assess the polarity of lentivirus entry into AEC, confluent polarized AEC monolayers (Rt > 2 k
· cm2) grown on tissue culture-treated
polycarbonate filters were incubated on day 4 with concentrated
lentivirus applied either to the apical or the basolateral surface for
1 h at 37°C. Rt was measured 30 min before
and 30 min and 3 days after infection. For infection from the apical
side, medium was aspirated and cells were incubated with 100 µl of
virus. For basolateral infection, medium was aspirated and the filter
was inverted before the addition of 40 µl of concentrated virus. In
some experiments, EGTA was first added at a final concentration of 4.5 mM to disrupt tight junctions, followed by the addition of virus to the
apical side as described above. Cells on filters at 72 h
postinfection were rinsed with PBS, trypsinized, washed, and
resuspended in PBS. To ensure cell recovery, filters were also flushed
once with PBS. Transduction efficiency after infection from either
apical or basolateral surface was assessed by FACS analysis as
described above.
Southern analysis of transduced AEC. Genomic DNA was harvested from AEC 72 h posttransduction by proteinase K digestion and phenol-chloroform extraction. A 10-µg portion was digested overnight with NotI, which yields a 2.2-kb internal fragment that encompasses EGFP, and then separated by agarose gel electrophoresis. After alkali denaturation, gels were transferred to Pall Biodyne B nylon membranes (Pall Biosupport Division, Port Washington, N.Y.) in 20× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) buffer. A 1.1-kb DNA probe specific for EGFP was labeled by using a random primer DNA biotinylation kit (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, Md.) and hybridized to the membranes in formamide hybridization buffer. Membranes were washed at high stringency, followed by incubation with alkaline phosphatase-streptavidin conjugate. After the washing, signal was detected by incubation with CDP-Star chemiluminescent substrate (Tropix, Inc., Bedford, Mass.) and exposure to X-ray film.
Viral transduction of RTEC. Cells grown on membranes maintained at ALI for 2 to 4 weeks were transduced by incubation with lentivirus (MOI = 5) applied to the apical surface for 2 h at 37°C. Infection was carried out as described above. To disrupt tight junctions, cells were pretreated in some experiments with EGTA in hypotonic solution (6 mM in 10 mM HEPES [pH 7.4]) as previously described (53). Transduction efficiency after infection from the apical surface was assayed by FACS analysis.
Confocal microscopy. AEC grown on chamber slides (Lab-Tek II; Nalge Nunc, Rochester, N.Y.) were infected with lentivirus on day 4. At 72 h after transduction, cells were rinsed, fixed in 2% paraformaldehyde, and mounted (ProLong Antifade Kit; Molecular Probes, Eugene, Oreg.). Cells were viewed with a PCM 2000 confocal microscopy system (Nikon USA, Melville, N.Y.).
Statistical analysis. Data are presented as mean ± the standard error of the mean. Significance (P < 0.05) of differences between two experimental conditions was assessed by use of unpaired Student t tests.
| |
RESULTS |
|---|
|
|
|---|
Lentivirus vectors achieve efficient transduction of AEC.
A
SIN lentivirus transfer vector encoding the EGFP marker gene was
packaged by a standard three-plasmid cotransfection procedure (33) to produce vectors pseudotyped with the VSV-G protein
(Fig. 1). The titers of unconcentrated vector supernatants generated by
this procedure are typically on the order of 5 × 106 TU/ml when titers were determined on 293T or
HeLa cells (data not shown). After concentration, titers on the order
of 108 TU/ml were achieved. These vectors were
used to transduce rat AEC in primary culture on day 4 postisolation,
after the AT2 cells grown on tissue culture-treated plastic surfaces
had progressed toward an AT1 cell-like phenotype. Consistent with
previous reports that AEC in culture are largely quiescent, FACS
analysis demonstrated that only 1.0% ± 0.1% of cells were labeled
with BrdU. Nevertheless, confocal microscopy of AEC grown on chamber
slides demonstrates strong expression of EGFP at 3 days
posttransduction in a majority of cells (Fig.
2A). Representative
FACS analysis at 3 days posttransduction shows a shifted population of
cells exhibiting higher fluorescence intensity specifically in the EGFP
wavelength (FL1 channel), with 99% GFP-positive cells, further
demonstrating that AEC are efficiently transduced by this vector
(Fig. 2B). Changing the plating density of AEC did not affect the
percentage of GFP-positive cells after incubation with the same
preparation of lentivirus, indicating that cell density has little
effect on transduction efficiency (data not shown). Comparison with
VSV-G-pseudotyped standard MLV-based retrovirus vectors of
comparable titer demonstrates ~30-fold greater transduction by the
lentivirus vectors (Fig. 2C). A reduction in the number of
GFP-expressing cells was observed after transduction by lentivirus
vectors in the presence of AZT (~75% inhibition at 200 µM AZT),
confirming that GFP expression is not due to pseudotransduction. Furthermore, Southern analysis demonstrates a 2.2-kb band of predicted size after NotI digestion and hybridization with a
GFP-specific probe, confirming vector integration (data not shown).
|
Transduction of AEC by lentivirus vectors is dose dependent.
To determine whether varying the MOI would alter the efficiency of gene
delivery by the lentivirus vectors, fixed numbers of AEC in primary
culture were plated, and replicate plates were subsequently challenged
with increasing dosages of the vectors. For this experiment, lentivirus
vector supernatants were first concentrated to produce a vector
preparation in the range of 2 × 108 TU/ml
(as determined by FACS analysis of transduced HeLa cells). A
dose-dependent increase in transduction efficiency of AEC was observed
with increasing MOI, with the EGFP-positive population ranging from 4 to 99% after infection at an MOI from 0.1 to 50 relative to the titers
determined on HeLa cells (Fig. 3).
Although transduction of AEC by VSV-G-pseudotyped lentivirus vectors is thus somewhat less efficient than transduction of HeLa cells, almost
complete transduction could be achieved by increasing the MOI. No
toxicity was noted at a higher MOI as reflected by lack of change in
morphology or cell number and the absence of a subpopulation of dead
cells observed by FACS analysis.
|
Polarity of AEC monolayer transduction by VSV-G-pseudotyped
lentivirus vectors.
AEC monolayers were infected with
VSV-G-pseudotyped lentivirus from either the apical or basolateral side
and analyzed by FACS at 3 days posttransduction (Fig.
4). VSV-G-pseudotyped lentivirus vectors
were somewhat unexpectedly preferentially transduced from the
apical surface with an efficiency of 31% ± 2% at an MOI of 10 (Fig.
4). Transduction from the apical side was ~25-fold higher than when
the virus was introduced from the basolateral surface. As shown in
Table 1, Rt
measurements taken before and after infection confirmed that the
integrity of the tight junctions was maintained, suggesting that
leakage to the basolateral side did not account for transduction when
the virus was introduced from the apical side.
|
|
· cm2 after addition of EGTA, there was no increase
in transduction by apically introduced virus, indicating that vector
leakage to the basolateral surface does not contribute significantly to
the observed level of transduction by VSV-G-pseudotyped
lentivirus vectors from the apical side.
RTEC transduction by VSV-G-pseudotyped lentivirus
vectors.
Differentiated RTEC maintained at ALI for 2 to 4 weeks
had mean Rt of 848 ± 16
· cm2. Proximal human airway epithelial
cells have previously been shown to be quiescent (19,
50). In contrast to AEC, apical transduction of RTEC resulted in
only rare (<1%) GFP-expressing cells (Fig.
5). This finding is consistent with
previous reports that human tracheobronchial cells are preferentially
transduced from the basolateral surface (19, 21). RTEC
were also treated with EGTA, causing the Rt to
fall to <15
· cm2. EGFP-expressing
cells were significantly increased (>15-fold) compared to the
percentage of cells transduced after apical application in the absence
of EGTA.
|
| |
DISCUSSION |
|---|
|
|
|---|
The alveolar epithelium is an attractive target for gene therapy for the treatment of a number of acute and chronic pulmonary diseases and, by virtue of its large surface area, for systemic delivery of therapeutic proteins. In addition, the development of techniques for high-efficiency transduction of primary AEC would facilitate investigations of the biological characteristics of these cells in vitro. In this study, we have demonstrated that VSV-G-pseudotyped lentivirus vectors efficiently transduce quiescent AEC in primary culture, with transduction being favored by virus application from the apical side in polarized monolayers. With their ability to integrate into the host genome, these findings suggest that lentivirus vectors may be advantageous for efficient transfer and long-term expression of transgenes in the distal respiratory tract.
Analysis by flow cytometry on day 4 demonstrated that ~1% of cells are labeled with BrdU, confirming the relatively quiescent state of AEC in vitro. Consistent with previous observations in other quiescent cell types (e.g., neurons) (34), we demonstrate that transduction of AEC with a VSV-G-pseudotyped lentivirus vector is highly efficient, with more than 90% of infected cells expressing GFP as determined by FACS analysis at the highest MOI. The reduction in GFP expression after transduction in the presence of AZT, together with the results of Southern analysis, make it likely that the observed GFP fluorescence reflects true transduction by the lentivirus vectors. Transduction of AEC by lentivirus vectors greatly exceeded that achieved with similarly pseudotyped MLV vectors. Despite concentration to relatively high titers facilitated by VSV-G pseudotyping, only low-level transduction of AEC by MLV-based vectors was observed in the current study. The low level of MLV vector transduction that we observed in AEC is consistent with previous reports of inefficient gene transfer by amphotropic MLV vectors in quiescent airway epithelial cells from trachea and bronchi, even after disruption of epithelial tight junctions to allow basolateral access (19, 21, 31). Together, these results demonstrate the superiority of VSV-G-pseudotyped lentivirus vectors for transduction of AEC relative to similarly pseudotyped MLV-based vectors at a comparable titer.
One of the important observations in gene transfer over the past decade has been that transduction is typically polarized. The apparent basolateral preference in airway epithelial cells has precluded the use of retrovirus and, additionally, has limited apical adenovirus gene transfer due, at least in part, to a preferential basolateral distribution of the adenovirus fiber protein receptors (36, 49). Although lentivirus-mediated gene transfer has the dual advantages of long-term expression by virtue of integration into the genome and transduction of quiescent cells, the vector has also been viewed as inefficient for pulmonary gene delivery due to reports of limited transduction by apically applied VSV-G-pseudotyped lentivirus vectors in the upper respiratory tract (19, 21). Therefore, assessment of the polarity of transduction was central to our investigation of lentivirus transduction of AEC. To address this, we utilized a well-characterized model in which AEC form tight monolayers with high transepithelial resistance and exhibit polarized distribution of a variety of membrane-associated proteins (e.g., Na channel and Na pump subunits) (7, 24, 39). Concurrent with the development of resistance, the cells undergo transition toward a type I cell-like phenotype, closely mimicking the properties of the alveolar epithelium in vivo (6). We found that polarized monolayers of primary AEC exhibiting high transepithelial resistance could be efficiently transduced when VSV-G-pseudotyped lentivirus vectors were introduced from the apical cell surface. In contrast, transduction of VSV-G-pseudotyped lentivirus vectors applied to the basolateral surface of AEC was markedly lower. Transduction efficiency of apically applied virus was also assessed after the addition of EGTA in order to facilitate access of the virus to the basolateral cell surface. Lack of an increase in transduction in the presence of EGTA, despite a marked reduction in Rt, suggests that AEC uptake of VSV-G-pseudotyped lentivirus occurs preferentially from the apical surface. By comparison, transduction of polarized RTEC by VSV-G-pseudotyped lentivirus was far lower from the apical surface and was significantly increased after disruption of tight junctions, a finding consistent with more efficient transduction from the basolateral cell surface in RTEC.
These observations in RTEC are similar to previous studies in which human bronchial or nasal airway epithelial cells in culture were 30-fold more efficiently transduced from the basolateral relative to the apical side by VSV-G-pseudotyped lentivirus, although the overall efficiency of transduction was not stated (21). In that study, enhanced in vivo gene transfer efficiency to the nasal and tracheal epithelium of rodents of a VSV-G-pseudotyped human lentivirus vector was observed after sulfur dioxide injury, presumably by increasing access of vector to the basolateral cell surface. Similarly, Goldman et al. (19) demonstrated that lentivirus vectors pseudotyped with VSV-G were able to transduce undifferentiated airway epithelia but failed to transduce the well-differentiated pseudostratified columnar epithelium in human bronchial xenografts, whereas Wang et al. (51) reported that feline immunodeficiency viral vectors pseudotyped with VSV-G could transduce differentiated airway epithelium in rabbits only in the presence of EGTA. Kobinger et al. (25), in a recent comparative analysis of the effects of pseudotyping on transduction, demonstrated similar low levels of apical transduction by VSV-G-pseudotyped lentivirus vectors in well-differentiated human airway epithelial cells.
Polarized gene transfer to epithelia can be mediated by a number of mechanisms, including differential distribution of viral receptors on apical and basolateral cell surfaces, inactivation or inaccessibility of viral receptors, or inactivation or inhibition of virus after entry. High-resistance monolayers of MDCK cells have previously been shown to be infected more efficiently from the basolateral cell surface by wild-type VSV (18). This has led to the presumption that the putative receptor for wild-type VSV (suggested to be a phospholipid such as phosphatidylserine) (41) is located on the basolateral surface of all polarized epithelia. It has similarly been hypothesized that a predominant basolateral distribution of amphotropic MLV retrovirus receptors in mature airway epithelia may account for the limited viral entry observed from the apical side for amphotropic vectors (30, 50). However, the precise distribution and/or function of cellular VSV-G receptors in airway or alveolar epithelia has not been characterized and could conceivably be different among various cell types. Consistent with this notion, more efficient apical transduction by VSV-G-pseudotyped lentivirus vectors has recently been demonstrated in intestinal epithelial cells (42), suggesting the presence of receptors for VSV-G on the apical cell surface in specific cell types.
In addition to the possibility of reversed polarity of VSV-G receptors in AEC compared with airway epithelium or other cell types, differential intracellular trafficking or processing of virus after infection from either surface could also account for the observed differences in transduction in polarized cells. Duan et al. (13) recently observed that, in human airway epithelia, preferential basolateral transduction of adeno-associated virus could be attributed to differences in endosomal processing of apically or basolaterally internalized virions. This difference in intracellular processing led to degradation and low levels of gene transfer of adeno-associated virus applied to the apical surface of polarized airway epithelia. Inhibition of this pathway led to an increase in apical gene delivery by more than 200-fold. The possibility that differences in the postendocytotic processing pathways between airway and alveolar epithelia may account for the differences in apical or basolateral transduction at these two sites requires further investigation.
The adaptation of lentiviruses such as HIV for use as gene transfer vectors, while achieving a high transduction efficiency in primary cells compared to standard murine retrovirus vectors, has raised concerns regarding inadvertent production of replication-competent virus. However, recent advances in lentivirus vector design have substantially reduced such concerns. The lentivirus vectors used in this study include only a very small fraction of the wild-type HIV genome (57). An added safety feature introduced in the SIN transfer vector is the deletion of U3 sequences in the 3' long terminal repeat (LTR), which is then also deleted in the 5' LTR during reverse transcription and eliminates production of full-length vector RNA (32, 57). This change further minimizes the likelihood of producing replication-competent lentivirus. Finally, since these replication-defective vectors do not themselves express any lentivirus proteins, they have not yet been noted to trigger an immune response against transduced cells in animal models (45).
In summary, we have demonstrated that VSV-G-pseudotyped lentivirus vectors efficiently transduce AEC in primary culture, with transduction being favored by virus application from the apical side. In contrast, transduction of RTEC by apically applied lentivirus was negligible. Transduction efficiency in AEC increased with increasing MOI and greatly exceeded that achieved with a similarly pseudotyped MLV retrovirus vector. The ability of these vectors to efficiently integrate into the quiescent cells of the alveolar epithelium in vitro suggests that, in contrast to the experience with airway epithelium, lentivirus vectors may be advantageous for achieving efficient gene transfer and long-term gene expression in the distal respiratory tract in vivo.
| |
ACKNOWLEDGMENTS |
|---|
Z.B. and J. E.H.-B. contributed equally to this study.
We note with appreciation the expert technical support of Martha Jean Foster and Suzie Parra.
This work was supported in part by the American Heart Association, the National Institutes of Health (grants HL38578, HL38621, HL 38658, HL62576, HL63988, HL 64365, and AR46366), the Baxter Foundation, and the Hastings Foundation. E. D. Crandall is Hastings Professor of Medicine and Kenneth T. Norris, Jr., Chair of Medicine.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Pulmonary and Critical Care Medicine, University of Southern California, GNH 11-900, 2025 Zonal Ave., Los Angeles, CA 90033. Phone: (323) 442-3329. Fax: (323) 442-2611. E-mail: zborok{at}hsc.usc.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Albelda, S. M.,
R. Wiewrodt, and J. B. Zuckerman.
2000.
Gene therapy for lung disease: hype or hope?
Ann. Intern. Med.
132:649-660 |
| 2. | Bertalanffy, F. D. 1964. Respiratory tissue: structure, histophysiology, cytodynamics. II. New approaches and interpretations. Int. Rev. Cytol. 17:213-297[Medline]. |
| 3. | Borok, Z., S. I. Danto, S. M. Zabski, and E. D. Crandall. 1994. Defined medium for primary culture de novo of adult rat alveolar epithelial cells. In Vitro Cell Dev. Biol. Anim. 30A:99-104. |
| 4. | Bowden, D. H., E. Davies, and J. P. Wyatt. 1968. Cytodynamics of pulmonary alveolar cells in the mouse. Arch. Pathol. 86:667-670[Medline]. |
| 5. | Brigham, K. L., and A. A. Stecenko. 2000. Gene therapy for acute lung injury. Intensive Care Med. 26:S119-S123. |
| 6. | Cheek, J. M., M. J. Evans, and E. D. Crandall. 1989. Type I cell-like morphology in tight alveolar epithelial monolayers. Exp. Cell Res. 184:375-387[CrossRef][Medline]. |
| 7. |
Cheek, J. M.,
K. J. Kim, and E. D. Crandall.
1989.
Tight monolayers of rat alveolar epithelial cells: bioelectric properties and active sodium transport.
Am. J. Physiol.
256:C688-C693 |
| 8. | Chirmule, N., K. Propert, S. Magosin, Y. Qian, R. Qian, and J. Wilson. 1999. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther. 6:1574-1583[CrossRef][Medline]. |
| 9. | Christensen, P. J., S. Kim, R. H. Simon, G. B. Toews, and R. D. Paine. 1993. Differentiation-related expression of ICAM-1 by rat alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 8:9-15. |
| 10. | Danto, S. I., S. M. Zabski, and E. D. Crandall. 1992. Reactivity of alveolar epithelial cells in primary culture with type I cell monoclonal antibodies. Am. J. Respir. Cell Mol. Biol. 6:296-306. |
| 11. | Dobbs, L. G., R. Gonzalez, and M. C. Williams. 1986. An improved method for isolating type II cells in high yield and purity. Am. Rev. Respir. Dis. 134:141-145[Medline]. |
| 12. | Dong, J. Y., D. Wang, F. W. Van Ginkel, D. W. Pascual, and R. A. Frizzell. 1996. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector. Hum. Gene Ther. 7:319-331[Medline]. |
| 13. | Duan, D., Y. Yue, Z. Yan, J. Yang, and J. F. Engelhardt. 2000. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J. Clin. Investig. 105:1573-1587[Medline]. |
| 14. | Engelhardt, J. F., J. R. Yankaskas, and J. M. Wilson. 1992. In vivo retroviral gene transfer into human bronchial epithelia of xenografts. J. Clin. Investig. 90:2598-2607. |
| 15. | Factor, P., F. Saldias, K. Ridge, V. Dumasius, J. Zabner, H. A. Jaffe, G. Blanco, M. Barnard, R. Mercer, R. Perrin, and J. I. Sznajder. 1998. Augmentation of lung liquid clearance via adenovirus-mediated transfer of a Na,K-ATPase beta1 subunit gene. J. Clin. Investig. 102:1421-1430[Medline]. |
| 16. |
Flotte, T. R.,
S. A. Afione,
C. Conrad,
S. A. McGrath,
R. Solow,
H. Oka,
P. L. Zeitlin,
W. B. Guggino, and B. J. Carter.
1993.
Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.
Proc. Natl. Acad. Sci. USA
90:10613-10617 |
| 17. | Flotte, T. R., S. A. Afione, and P. L. Zeitlin. 1994. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell Mol. Biol. 11:517-521[Abstract]. |
| 18. | Fuller, S., C. H. von Bonsdorff, and K. Simons. 1984. Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK. Cell 38:65-77[CrossRef][Medline]. |
| 19. | Goldman, M. J., P. S. Lee, J. S. Yang, and J. M. Wilson. 1997. Lentiviral vectors for gene therapy of cystic fibrosis. Hum. Gene Ther. 8:2261-2268[Medline]. |
| 20. | Grimm, D., and J. A. Kleinschmidt. 1999. Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum. Gene Ther. 10:2445-2450[CrossRef][Medline]. |
| 21. | Johnson, L. G., J. C. Olsen, L. Naldini, and R. C. Boucher. 2000. Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo. Gene Ther. 7:568-574[CrossRef][Medline]. |
| 22. | Kaartinen, L., P. Nettesheim, K. B. Adler, and S. H. Randell. 1993. Rat tracheal epithelial cell differentiation in vitro. In Vitro Cell Dev. Biol. Anim. 29A:481-492[CrossRef]. |
| 23. | Kafri, T., U. Blomer, D. A. Peterson, F. H. Gage, and I. M. Verma. 1997. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17:314-317[Medline]. |
| 24. |
Kim, K. J.,
J. M. Cheek, and E. D. Crandall.
1991.
Contribution of active Na+ and Cl fluxes to net ion transport by alveolar epithelium.
Respir. Physiol.
85:245-256[CrossRef][Medline].
|
| 25. | Kobinger, G. P., D. J. Weiner, Q. C. Yu, and J. M. Wilson. 2001. Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19:225-230[CrossRef][Medline]. |
| 26. | Leslie, C. C., K. McCormick-Shannon, J. L. Cook, and R. J. Mason. 1985. Macrophages stimulate DNA synthesis in rat alveolar type II cells. Am. Rev. Respir. Dis. 132:1246-1252[Medline]. |
| 27. | Leslie, C. C., K. McCormick-Shannon, P. C. Robinson, and R. J. Mason. 1985. Stimulation of DNA synthesis in cultured rat alveolar type II cells. Exp. Lung Res. 8:53-66[Medline]. |
| 28. | Leslie, C. C., K. McCormick-Shannon, J. M. Shannon, B. Garrick, D. Damm, J. A. Abraham, and R. J. Mason. 1997. Heparin-binding EGF-like growth factor is a mitogen for rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 16:379-387[Abstract]. |
| 29. | Mason, R. J., S. R. Walker, B. A. Shields, J. E. Henson, and M. C. Williams. 1985. Identification of rat alveolar type II epithelial cells with a tannic acid and polychrome stain. Am. Rev. Respir. Dis. 131:786-788[Medline]. |
| 30. |
Miller, A. D.
1996.
Cell-surface receptors for retroviruses and implications for gene transfer.
Proc. Natl. Acad. Sci. USA
93:11407-11413 |
| 31. |
Miller, D. G.,
M. A. Adam, and A. D. Miller.
1990.
Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection.
Mol. Cell. Biol.
10:4239-4242 |
| 32. |
Miyoshi, H.,
U. Blomer,
M. Takahashi,
F. H. Gage, and I. M. Verma.
1998.
Development of a self-inactivating lentivirus vector.
J. Virol.
72:8150-8157 |
| 33. | Naldini, L. 1998. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 9:457-463[CrossRef][Medline]. |
| 34. | Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267[Abstract]. |
| 35. | Ostrowski, L. E., S. H. Randell, A. B. Clark, T. E. Gray, and P. Nettesheim. 1995. Ciliogenesis of rat tracheal epithelial cells in vitro. Methods Cell Biol. 47:57-63[Medline]. |
| 36. |
Pickles, R. J.,
D. McCarty,
H. Matsui,
P. J. Hart,
S. H. Randell, and R. C. Boucher.
1998.
Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer.
J. Virol.
72:6014-6023 |
| 37. | Polonovsky, V., and P. B. Bitterman. 1997. Regulation of cell population size, p. 133-144. In J. B. West, and R. G. Crystal (ed.), The lung: scientific foundations, 2nd ed., vol. 1. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 38. | Reiser, J. 2000. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther. 7:910-913[CrossRef][Medline]. |
| 39. |
Russo, R. M.,
R. L. Lubman, and E. D. Crandall.
1992.
Evidence for amiloride-sensitive sodium channels in alveolar epithelial cells.
Am. J. Physiol.
262:L405-L411 |
| 40. | Sakoda, T., N. Kasahara, Y. Hamamori, and L. Kedes. 1999. A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J. Mol. Cell. Cardiol. 31:2037-2047[CrossRef][Medline]. |
| 41. | Schlegel, R., T. S. Tralka, M. C. Willingham, and I. Pastan. 1983. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 32:639-646[CrossRef][Medline]. |
| 42. |
Seppen, J.,
S. C. Barry,
J. H. Klinkspoor,
L. J. Katen,
S. P. Lee,
J. V. Garcia, and W. R. Osborne.
2000.
Apical gene transfer into quiescent human and canine polarized intestinal epithelial cells by lentivirus vectors.
J. Virol.
74:7642-7645 |
| 43. | Sisson, T. H., N. Hattori, Y. Xu, and R. H. Simon. 1999. Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes. Hum. Gene Ther. 10:2315-2323[CrossRef][Medline]. |
| 44. |
Soneoka, Y.,
P. M. Cannon,
E. E. Ramsdale,
J. C. Griffiths,
G. Romano,
S. M. Kingsman, and A. J. Kingsman.
1995.
A transient three-plasmid expression system for the production of high titer retroviral vectors.
Nucleic Acids Res.
23:628-633 |
| 45. | Trono, D. 2000. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther. 7:20-23[CrossRef][Medline]. |
| 46. |
Uhal, B. D.
1997.
Cell cycle kinetics in the alveolar epithelium.
Am. J. Physiol.
272:L1031-L1045 |
| 47. |
Uhal, B. D., and M. D. Etter.
1993.
Type II pneumocyte hypertrophy without activation of surfactant biosynthesis after partial pneumonectomy.
Am. J. Physiol.
264:L153-L159 |
| 48. |
Uhal, B. D., and D. E. Rannels.
1991.
DNA distribution analysis of type II pneumocytes by laser flow cytometry: technical considerations.
Am. J. Physiol.
261:L296-L306 |
| 49. |
Walters, R. W.,
T. Grunst,
J. M. Bergelson,
R. W. Finberg,
M. J. Welsh, and J. Zabner.
1999.
Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia.
J. Biol. Chem.
274:10219-10226 |
| 50. |
Wang, G.,
B. L. Davidson,
P. Melchert,
V. A. Slepushkin,
H. H. van Es,
M. Bodner,
D. J. Jolly, and P. B. McCray.
1998.
Influence of cell polarity on retrovirus-mediated gene transfer to differentiated human airway epithelia.
J. Virol.
72:9818-9826 |
| 51. | Wang, G., V. Slepushkin, J. Zabner, S. Keshavjee, J. C. Johnston, S. L. Sauter, D. J. Jolly, T. W. Dubensky, Jr., B. L. Davidson, and P. B. McCray, Jr. 1999. Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J. Clin. Investig. 104:R55-R62. |
| 52. | Wang, G., V. A. Slepushkin, M. Bodner, J. Zabner, H. H. van Es, P. Thomas, D. J. Jolly, B. L. Davidson, and P. B. McCray. 1999. Keratinocyte growth factor induced epithelial proliferation facilitates retroviral-mediated gene transfer to distal lung epithelia in vivo. J. Gene Med. 1:22-30[CrossRef][Medline]. |
| 53. |
Wang, G.,
J. Zabner,
C. Deering,
J. Launspach,
J. Shao,
M. Bodner,
D. J. Jolly,
B. L. Davidson, and P. B. McCray, Jr.
2000.
Increasing epithelial junction permeability enhances gene transfer to airway epithelia in vivo.
Am. J. Respir. Cell Mol. Biol.
22:129-138 |
| 54. | Welsh, M. J. 1999. Gene transfer for cystic fibrosis. J. Clin. Investig. 104:1165-1166[Medline]. |
| 55. | Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015[Abstract]. |
| 56. | Zabner, J. 1997. Cationic lipids used in gene transfer. Adv. Drug Deliv. Rev. 27:17-28[CrossRef][Medline]. |
| 57. |
Zufferey, R.,
T. Dull,
R. J. Mandel,
A. Bukovsky,
D. Quiroz,
L. Naldini, and D. Trono.
1998.
Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.
J. Virol.
72:9873-9880 |
| 58. | Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15:871-875[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»